Clinical Trials List
2026-10-01 - 2030-03-31
Phase II/III
Not yet recruiting5
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- Yen-Chung Lin Division of Nephrology
- 陳靜怡 Division of Nephrology
- Chih-Chin Kao Division of Nephrology
- Hsi-Hsien Chen Division of Nephrology
- Te-Chao Fang Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Cai-Mei Zheng Division of Nephrology
- Mei-Yi Wu Division of Nephrology
- 高芷華 Division of Nephrology
- Chia-Te Liao Division of Nephrology
- Li-Yee Hong Division of Nephrology
- Yu-Wei Chen Division of Nephrology
- 林冠宏 Division of Nephrology
- YUNG-HO HSU Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- WEN-CHIH CHIANG Division of General Internal Medicine
- - - Division of General Internal Medicine
- 趙家德 Division of General Internal Medicine
- 黃道民 Division of General Internal Medicine
- 蘇祺婷 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- Cheng-Chia Lee Division of Nephrology
- Kun-Hua Tu Division of Nephrology
- 吳欣旭 Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
265 participants
